Jim Simons's position in Zevra Therapeutics is currently worth $991 Thousand. That's 0.00% of their equity portfolio (2270th largest holding). The first Zevra Therapeutics trade was made in Q3 2021. Since then Jim Simons bought shares six more times and sold shares on three occasions. The investor's estimated purchase price is $1.36 Million, resulting in a loss of 27%.